Royalty Pharma plc (RPRX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 760.54M | 827.15M | 702.62M | 363.98M | 596.08M | 742.52M | 703.61M | 658.21M | 664.64M | 772.63M | 573.52M | 607.82M | 1.03B | 569.93M | 538.83M | 574.95M | 460.27M | 489.96M | 469.76M | 531.72M |
| Operating CF Margin % | 120.53% | 132.98% | 115.32% | 62.9% | 104.9% | 125.08% | 124.6% | 122.51% | 117.02% | 129.62% | 106.94% | 112.93% | 151.15% | 100.74% | 93.96% | 107.28% | 81.89% | 85.11% | 80.19% | 95.81% |
| Operating CF Growth % | 27.59% | 11.4% | -0.14% | -44.7% | -10.32% | -3.9% | 22.68% | 8.29% | -35.71% | 35.57% | 6.44% | 5.72% | 124.62% | 16.32% | 14.7% | 8.13% | -12.51% | -13.39% | -7.68% | 8.74% |
| Net Income | 294.69M | 355.91M | 444.21M | 90.64M | 433.43M | 334.35M | 806.36M | 194.38M | -4.27M | 717.59M | 122.08M | 351.34M | 509.09M | -610.03M | 220.41M | 491.6M | 128.08M | 53.67M | 221.8M | 806.75M |
| Depreciation & Amortization | 1.17M | 1.2M | 1.28M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.67M | 5.8M | 5.8M | 5.73M |
| Stock-Based Compensation | 0 | 125.77M | 72.84M | 90.77M | 515K | 525K | 526K | 681K | 612K | 617K | 581K | 586K | 573K | 583K | 582K | 509K | 496K | 504K | 505K | 721K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -370.5M | 295.76M | 235.16M | 132.89M | 226.6M | 356.13M | -84.55M | 413.07M | 697.79M | 6.51M | 487.88M | 218.26M | 567.31M | 1.15B | 348.81M | 4.44M | 365.73M | 383.95M | 304.63M | -315.07M |
| Working Capital Changes | 835.18M | 48.51M | -50.88M | 49.69M | -64.48M | 51.52M | -18.72M | 50.08M | -29.5M | 47.91M | -37.02M | 37.63M | -43.14M | 24.95M | -30.98M | 78.41M | -39.71M | 46.04M | -62.97M | 33.58M |
| Change in Receivables | 1.8M | -415K | -1.16M | -3.96M | 3.17M | -2.06M | -1.32M | -1.35M | 178K | 1.27M | -2.68M | 3.21M | -1.2M | -1.75M | 504K | 30.46M | 2.5M | 5.19M | -28.66M | -4.84M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -5.08M | -28.53M | 10.91M | -6.39M | 10.09M | -5.87M | 7.2M | -6K | -3.61M | 4.59M | 3.79M | -888K | -1.25M | -8.21M | 3.94M | 5.51M | 1.04M | -2.45M | -1.23M | 1.29M |
| Cash from Investing | -520.17M | -847.8M | -958.31M | -311.98M | 503.92M | -505.59M | -1.19B | -893.18M | -86.65M | -1B | -450.66M | -63.43M | -558.53M | 414.74M | -1.43B | -30.18M | 11.16M | -551.65M | -845.5M | 126.17M |
| Capital Expenditures | -452.37M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | 71.69% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | -226K | -74.19M | 0 | 0 | 0 | -3.98M | -6.97M | -1.99M | -3.98M | -2.99M | -3.58M | 0 | -6.85M | 0 | -3.05M | -6.54M | -10.89M | -8.71M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -50M | 2.28M | 905K | -164.56M | -13.74M | -21.76M | 11.49M | -44.02M | 4.96M | 2.62M | 4.46M | 0 | 22.37M | 0 | 0 | 0 | 0 | 0 | 0 | -18.08M |
| Cash from Financing | -272.67M | -299.6M | 562.74M | -507.81M | -941.3M | -257.96M | -325.5M | 1.16B | -212M | -231.89M | -1.36B | -347M | -210.37M | -265.55M | -230.09M | -228.25M | -220.97M | -198.07M | 1.03B | -224.41M |
| Debt Issued (Net) | 0 | 0 | 954.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.27B | 0 |
| Equity Issued (Net) | -50.1M | -80.54M | -146.49M | -291.57M | -708.78M | -52.61M | -97.05M | -80M | 0 | -30.2M | -140.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | -104.49M | -94.34M | -95.31M | -93.24M | -95.36M | -93.66M | -94.06M | -94.94M | -93.81M | -89.34M | -89.75M | -90.61M | -88.63M | -84.2M | -83.81M | -83.05M | -82.26M | -73.6M | -73.02M | -72.58M |
| Share Repurchases | -50.1M | -80.54M | -146.49M | -291.57M | -708.78M | -52.61M | -97.05M | -80M | 0 | -30.2M | -140.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -118.08M | -124.72M | -149.94M | -123M | -137.16M | -111.7M | -134.4M | 1.33B | -118.19M | -112.36M | -129.62M | -256.39M | -121.74M | -181.35M | -146.28M | -145.21M | -138.7M | -124.47M | -165.25M | -151.83M |
| Net Change in Cash | -32.3M | -320.25M | 307.04M | -455.81M | 158.69M | -21.03M | -814.59M | 921.64M | 365.99M | -459.44M | -1.24B | 197.39M | 264.94M | 719.12M | -1.12B | 316.52M | 250.47M | -259.76M | 658.53M | 433.47M |
| Free Cash Flow | 760.54M | 827.15M | 702.62M | 363.98M | 596.08M | 742.52M | 703.61M | 658.21M | 664.64M | 772.63M | 573.52M | 607.82M | 1.03B | 569.93M | 538.83M | 574.95M | 460.27M | 489.96M | 469.76M | 531.72M |
| FCF Margin % | 120.53% | 132.98% | 115.32% | 62.9% | 104.9% | 125.08% | 124.6% | 122.51% | 117.02% | 129.62% | 106.94% | 112.93% | 151.15% | 100.74% | 93.96% | 107.28% | 81.89% | 85.11% | 80.19% | 95.81% |
| FCF Growth % | 27.59% | 11.4% | -0.14% | -44.7% | -10.32% | -3.9% | 22.68% | 8.29% | -35.71% | 35.57% | 6.44% | 5.72% | 124.62% | 16.32% | 14.7% | 8.13% | -12.51% | -13.39% | -7.68% | 8.74% |
| FCF per Share | 1.36 | 1.48 | 1.26 | 0.65 | 1.03 | 1.26 | 1.19 | 1.10 | 1.11 | 1.28 | 0.95 | 1.00 | 1.70 | 1.09 | 0.89 | 0.95 | 0.76 | 0.96 | 0.77 | 0.88 |
| FCF Conversion (FCF/Net Income) | 2.58x | 3.86x | 2.44x | 12.06x | 2.50x | 3.57x | 1.29x | 6.45x | 139.10x | 1.56x | 7.95x | 2.67x | 3.03x | -1.25x | 3.78x | 1.89x | 8.89x | 61.99x | 4.61x | 1.21x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |